130 related articles for article (PubMed ID: 9693220)
21. Angiogenesis in portal hypertension: involvement in increased splanchnic blood flow and collaterals?
Geerts AM; Colle I
Acta Clin Belg; 2007; 62(5):271-5. PubMed ID: 18229459
[No Abstract] [Full Text] [Related]
22. Splanchnic hyposensitivity to glypressin in a hemorrhage-transfused common bile duct-ligated rat model of portal hypertension: role of nitric oxide and bradykinin.
Chen CT; Chu CJ; Lee FY; Chang FY; Wang SS; Lin HC; Hou MC; Wu SL; Chan CC; Huang HC; Lee SD
Hepatogastroenterology; 2009; 56(94-95):1261-7. PubMed ID: 19950773
[TBL] [Abstract][Full Text] [Related]
23. Pathophysiology of portal hypertension.
Cichoz-Lach H; Celiński K; Słomka M; Kasztelan-Szczerbińska B
J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():231-8. PubMed ID: 18812641
[TBL] [Abstract][Full Text] [Related]
24. The role of nitric oxide in the hyperdynamic circulatory syndrome associated with portal hypertension.
Sogni P; Moreau R; Gadano A; Lebrec D
J Hepatol; 1995 Aug; 23(2):218-24. PubMed ID: 7499796
[No Abstract] [Full Text] [Related]
25. Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension.
Laviña B; Gracia-Sancho J; Rodríguez-Vilarrupla A; Chu Y; Heistad DD; Bosch J; García-Pagán JC
Gut; 2009 Jan; 58(1):118-25. PubMed ID: 18829979
[TBL] [Abstract][Full Text] [Related]
26. Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension.
Wu Y; Burns RC; Sitzmann JV
Hepatology; 1993 Dec; 18(6):1416-21. PubMed ID: 8244267
[TBL] [Abstract][Full Text] [Related]
27. Nitric oxide and portal hypertension: a nitric oxide-releasing derivative of ursodeoxycholic acid that selectively releases nitric oxide in the liver.
Fiorucci S; Antonelli E; Morelli A
Dig Liver Dis; 2003 May; 35 Suppl 2():S61-9. PubMed ID: 12846445
[TBL] [Abstract][Full Text] [Related]
28. Leptin receptor blockade reduces intrahepatic vascular resistance and portal pressure in an experimental model of rat liver cirrhosis.
Delgado MG; Gracia-Sancho J; Marrone G; Rodríguez-Vilarrupla A; Deulofeu R; Abraldes JG; Bosch J; García-Pagán JC
Am J Physiol Gastrointest Liver Physiol; 2013 Oct; 305(7):G496-502. PubMed ID: 23886859
[TBL] [Abstract][Full Text] [Related]
29. Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis.
Gatta A; Bolognesi M; Merkel C
Mol Aspects Med; 2008; 29(1-2):119-29. PubMed ID: 18036654
[TBL] [Abstract][Full Text] [Related]
30. [Effects of neuropeptide Y on hemodynamics and sodium secretion in cirrhotic rats with portal hypertension].
Zhou J; Wang T; Tang W; Liang K
Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):147. PubMed ID: 11983141
[No Abstract] [Full Text] [Related]
31. Liposome-mediated gene transfer of endothelial nitric oxide synthase to cirrhotic rat liver decreases intrahepatic vascular resistance.
Zhang ZQ; Qiu JF; Luo M; Sun YW; Zhao G; Chen W; Liu H; Wu ZY
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e487-93. PubMed ID: 18070013
[TBL] [Abstract][Full Text] [Related]
32. Circulatory effects of graded diversion of portal blood flow to the systemic circulation in rats: role of nitric oxide.
Bernadich C; Bandi JC; Piera C; Bosch J; Rodes J
Hepatology; 1997 Aug; 26(2):262-7. PubMed ID: 9252132
[TBL] [Abstract][Full Text] [Related]
33. Role of nitric oxide in endotoxin-induced hepatic microvascular dysfunction in rats chronically fed ethanol.
Horie Y; Kimura H; Kato S; Ohki E; Tamai H; Yamagishi Y; Ishii H
Alcohol Clin Exp Res; 2000 Jun; 24(6):845-51. PubMed ID: 10888073
[TBL] [Abstract][Full Text] [Related]
34. Does altered regulation of ecNOS in sinusoidal endothelial cells determine increased intrahepatic resistance leading to portal hypertension?
Clemens MG
Hepatology; 1998 Jun; 27(6):1745-7. PubMed ID: 9620353
[No Abstract] [Full Text] [Related]
35. Endothelin-1 modulates intrahepatic resistance in a rat model of noncirrhotic portal hypertension.
Kamath PS; Tyce GM; Miller VM; Edwards BS; Rorie DK
Hepatology; 1999 Aug; 30(2):401-7. PubMed ID: 10421647
[TBL] [Abstract][Full Text] [Related]
36. Improvement of portal hypertension and hepatic blood flow in cirrhotic rats by oestrogen.
Sakamoto M; Ueno T; Nakamura T; Sakata R; Hasimoto O; Torimura T; Sata M
Eur J Clin Invest; 2005 Mar; 35(3):220-5. PubMed ID: 15733078
[TBL] [Abstract][Full Text] [Related]
37. Statins and portal hypertension: a new pharmacological challenge.
Ramírez G; Briceño J; Rojas A
Curr Vasc Pharmacol; 2012 Nov; 10(6):767-72. PubMed ID: 22272892
[TBL] [Abstract][Full Text] [Related]
38. [Correlative study between portal vein pressure and portal hemodynamics in patients with portal hypertension].
Liu Y; Li L; Yu Z; Liu Q; Li Z; Wang Y; Zhang Q
Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):135-7. PubMed ID: 11983136
[TBL] [Abstract][Full Text] [Related]
39. The pathophysiology of portal hypertension.
Treiber G; Csepregi A; Malfertheiner P
Dig Dis; 2005; 23(1):6-10. PubMed ID: 15920320
[TBL] [Abstract][Full Text] [Related]
40. High-frequency vagus nerve stimulation improves portal hypertension in cirrhotic rats.
Bockx I; Verdrengh K; Vander Elst I; van Pelt J; Nevens F; Laleman W; Cassiman D
Gut; 2012 Apr; 61(4):604-12. PubMed ID: 22187073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
